Cargando…

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Liver functional capacity is a crucial survival determinant for hepatocellular carcinoma (HCC). Noninvasive models were proposed to assess hepatic reserve, but their performance in outcome prediction is unclear. We aimed to investigate 10 currently used liver function models in HCC patients undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Chiou, Yi-You, Su, Chien-Wei, Lee, Yun-Hsuan, Huang, Yi-Hsiang, Lee, Fa-Yauh, Hou, Ming-Chih, Huo, Teh-Ia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770426/
https://www.ncbi.nlm.nih.gov/pubmed/29339752
http://dx.doi.org/10.1038/s41598-018-19251-y
_version_ 1783293066459742208
author Ho, Shu-Yein
Liu, Po-Hong
Hsu, Chia-Yang
Chiou, Yi-You
Su, Chien-Wei
Lee, Yun-Hsuan
Huang, Yi-Hsiang
Lee, Fa-Yauh
Hou, Ming-Chih
Huo, Teh-Ia
author_facet Ho, Shu-Yein
Liu, Po-Hong
Hsu, Chia-Yang
Chiou, Yi-You
Su, Chien-Wei
Lee, Yun-Hsuan
Huang, Yi-Hsiang
Lee, Fa-Yauh
Hou, Ming-Chih
Huo, Teh-Ia
author_sort Ho, Shu-Yein
collection PubMed
description Liver functional capacity is a crucial survival determinant for hepatocellular carcinoma (HCC). Noninvasive models were proposed to assess hepatic reserve, but their performance in outcome prediction is unclear. We aimed to investigate 10 currently used liver function models in HCC patients undergoing radiofrequency ablation (RFA). A total 499 HCC patients were prospectively identified. Homogeneity and corrected Akaike information criteria (AICc) were compared. Cox proportional hazards model was used to identify independent survival predictors. Significance survival differences were found across 10 noninvasive models (all p < 0.001) except for GUCI and APRI grade 2 vs 3, and King’s score grade 1 vs 2. Among these models, ALBI grade showed the highest homogeneity and lowest AICs value, indicating a better prognostic performance. Within Child-Turcotte-Pugh (CTP) score 5 group, significant survival difference was demonstrated between ALBI grade 1 and 2 (p < 0.001); for those with CTP score 6 or higher, only ALBI grade 2 and 3 showed survival difference (p < 0.001). Cox analysis disclosed that ALBI grade, tumor size and performance status were independent prognostic predictors. There was significant correlation between CTP score and other 9 models. We conclude that ALBI grade may serve as objective and feasible surrogate for prognostic prediction in HCC patients undergoing RFA.
format Online
Article
Text
id pubmed-5770426
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57704262018-01-26 Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Ho, Shu-Yein Liu, Po-Hong Hsu, Chia-Yang Chiou, Yi-You Su, Chien-Wei Lee, Yun-Hsuan Huang, Yi-Hsiang Lee, Fa-Yauh Hou, Ming-Chih Huo, Teh-Ia Sci Rep Article Liver functional capacity is a crucial survival determinant for hepatocellular carcinoma (HCC). Noninvasive models were proposed to assess hepatic reserve, but their performance in outcome prediction is unclear. We aimed to investigate 10 currently used liver function models in HCC patients undergoing radiofrequency ablation (RFA). A total 499 HCC patients were prospectively identified. Homogeneity and corrected Akaike information criteria (AICc) were compared. Cox proportional hazards model was used to identify independent survival predictors. Significance survival differences were found across 10 noninvasive models (all p < 0.001) except for GUCI and APRI grade 2 vs 3, and King’s score grade 1 vs 2. Among these models, ALBI grade showed the highest homogeneity and lowest AICs value, indicating a better prognostic performance. Within Child-Turcotte-Pugh (CTP) score 5 group, significant survival difference was demonstrated between ALBI grade 1 and 2 (p < 0.001); for those with CTP score 6 or higher, only ALBI grade 2 and 3 showed survival difference (p < 0.001). Cox analysis disclosed that ALBI grade, tumor size and performance status were independent prognostic predictors. There was significant correlation between CTP score and other 9 models. We conclude that ALBI grade may serve as objective and feasible surrogate for prognostic prediction in HCC patients undergoing RFA. Nature Publishing Group UK 2018-01-16 /pmc/articles/PMC5770426/ /pubmed/29339752 http://dx.doi.org/10.1038/s41598-018-19251-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ho, Shu-Yein
Liu, Po-Hong
Hsu, Chia-Yang
Chiou, Yi-You
Su, Chien-Wei
Lee, Yun-Hsuan
Huang, Yi-Hsiang
Lee, Fa-Yauh
Hou, Ming-Chih
Huo, Teh-Ia
Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
title Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
title_full Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
title_fullStr Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
title_full_unstemmed Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
title_short Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
title_sort prognostic performance of ten liver function models in patients with hepatocellular carcinoma undergoing radiofrequency ablation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770426/
https://www.ncbi.nlm.nih.gov/pubmed/29339752
http://dx.doi.org/10.1038/s41598-018-19251-y
work_keys_str_mv AT hoshuyein prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT liupohong prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT hsuchiayang prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT chiouyiyou prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT suchienwei prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT leeyunhsuan prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT huangyihsiang prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT leefayauh prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT houmingchih prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation
AT huotehia prognosticperformanceoftenliverfunctionmodelsinpatientswithhepatocellularcarcinomaundergoingradiofrequencyablation